Ans: A. Chemotherapy in hormone receptor positive patients(Ref Harrison I9/e p528; DX:Multigene tests.Uses:To guide chemotherapy decisions for,Node-negative cases.Hormone receptor-positive cases.HER2-negative breast cancer.Used clinically for early-stage breast cancer predicting recurrence risk & guide adjuvant chemotherapy decisions.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.